Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiromasa Inoue

Showing results (1-10 of 245) with videos related to

Pageof 25
Sort By:
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|September 8, 2006
[Airway hypersensitivity]Hiromasa Inoue
Arerugi = [Allergy]|May 5, 2006
[Allergic asthma and intrinsic inhibitors of cytokine signaling]Hiromasa Inoue
Expert Reviews in Molecular Medicine|October 21, 2004
SOCS proteins in T helper cell differentiation: implications for allergic disorders?Hiromasa Inoue, Masato Kubo
Arerugi = [Allergy]|March 11, 2014
[Airway immune responses in asthma]Kentaro Machida, Hiromasa Inoue
Nihon Rinsho. Japanese Journal of Clinical Medicine|August 19, 2010
[Drug dependency and drug-related sudden death]Hiromasa Inoue, Masayuki Nata
Current Allergy and Asthma Reports|February 16, 2006
Suppressor of cytokine signaling 3 (SOCS3) in Th2 cells evokes Th2 cytokines, IgE, and eosinophiliaMasato Kubo, Hiromasa Inoue
Allergology International : Official Journal of the Japanese Society of Allergology|March 20, 2018
Epidemiology of asthma-chronic obstructive pulmonary disease overlap (ACO)Akifumi Uchida, Kohta Sakaue, Hiromasa Inoue
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|December 28, 2004
SC-19220, antagonist of prostaglandin E2 receptor EP1, inhibits osteoclastogenesis by RANKLToshiyuki Tsujisawa, Hiromasa Inoue, Tatsuji Nishihara
Molecules (Basel, Switzerland)|June 15, 2013
Novel biological activities of allosamidinsShohei Sakuda, Hiromasa Inoue, Hiromichi Nagasawa
Nihon Rinsho. Japanese Journal of Clinical Medicine|June 4, 2016
[Distinguishing asthma from COPD]Kouhei Ohara, Takuya Samukawa, Hiromasa Inoue
Pageof 25

Showing results (1-10 of 245) with videos related to

Sort By:
Pageof 25
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|September 8, 2006
[Airway hypersensitivity]Hiromasa Inoue
Arerugi = [Allergy]|May 5, 2006
[Allergic asthma and intrinsic inhibitors of cytokine signaling]Hiromasa Inoue
Expert Reviews in Molecular Medicine|October 21, 2004
SOCS proteins in T helper cell differentiation: implications for allergic disorders?Hiromasa Inoue, Masato Kubo
Arerugi = [Allergy]|March 11, 2014
[Airway immune responses in asthma]Kentaro Machida, Hiromasa Inoue
Nihon Rinsho. Japanese Journal of Clinical Medicine|August 19, 2010
[Drug dependency and drug-related sudden death]Hiromasa Inoue, Masayuki Nata
Current Allergy and Asthma Reports|February 16, 2006
Suppressor of cytokine signaling 3 (SOCS3) in Th2 cells evokes Th2 cytokines, IgE, and eosinophiliaMasato Kubo, Hiromasa Inoue
Allergology International : Official Journal of the Japanese Society of Allergology|March 20, 2018
Epidemiology of asthma-chronic obstructive pulmonary disease overlap (ACO)Akifumi Uchida, Kohta Sakaue, Hiromasa Inoue
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|December 28, 2004
SC-19220, antagonist of prostaglandin E2 receptor EP1, inhibits osteoclastogenesis by RANKLToshiyuki Tsujisawa, Hiromasa Inoue, Tatsuji Nishihara
Molecules (Basel, Switzerland)|June 15, 2013
Novel biological activities of allosamidinsShohei Sakuda, Hiromasa Inoue, Hiromichi Nagasawa
Nihon Rinsho. Japanese Journal of Clinical Medicine|June 4, 2016
[Distinguishing asthma from COPD]Kouhei Ohara, Takuya Samukawa, Hiromasa Inoue
Pageof 25